Ivermectin as a Treatment for Covid-19

Ivermectin has been rejected by the FDA as a treatment for Covid-19 based on the studies that concluded it is not an effective treatment. However most studies show that it is an effective treatment for early treatment of Covid-19. Most of the studies that showed that it is not effective were done with late-stage disease, low dose Ivermectin, and short treatment period. It appears that the FDA is biased to use the Covid-19 "vaccines" which enriches big pharmaceutical companies. The CDC continues to push the notion that the Covid-19 Vaccines are "safe and effective" despite all the vaccine related injuries and deaths reported on VAERS and the fact that the vaccine does not prevent the disease or transmission. The CDC actually changed the definition of "vaccine" because the Covid-19 "vaccines" did not meet the CDC's own definition of a vaccine.

Studies on Ivermectin Against COVID-19 Date Journal Participants Outcome





Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept study 2020 Biomedical Research 35 Positive
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management July 8, 2020 Preprint 87 Positive
Safety and Efficacy of the Combined Use of Ivermectin, Dexamethasone, Enoxaparin and Aspirin Against COVID-19 Sept. 15, 2020 Preprint 167 Positive
Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel Nov. 17, 2020 Journal of Biomedical Research and Clinical Investigation 229 Positive
Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomised Clinical Trial Feb. 1, 2021 Journal of Clinical and Diagnostic Research 203 contacts to 52 index cases Positive
Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate Disease Feb. 5, 2021 Preprint 86 Positive
A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients Feb. 25, 2021 Eurasian Journal of Medicine and Oncology 116 Positive
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial May 2021 International Journal of International Medical Research 363 Positive
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19 May 2021 Journal of Medical Virology 113 Positive
Controlled Randomized Clinical Trial on Using Ivermectin with Doxycycline for Treating COVID-19 Patients in Baghdad, Iraq May 6, 2021 Iraqi Journal of Medical Sciences 140 Positive
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 June 15, 2021 International Journal of Nanomedicine 114 Positive
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study Aug. 13, 2021 Cureus 271 Positive
Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina Sept-Oct, 2021 American Journal of Therapeutics 234 Positive
Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients Feb. 9, 2022 Future Microbiology 24 Positive
Randomized trials – Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers June 21, 2022 Research, Society and Development 254 Positive
The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial July 7, 2022 International Journal of Infectious Diseases 89 Positive
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial Feb. 1, 2021 The Lancet 24 Mixed
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial April 2021 International Journal of Infectious Diseases 3037 Mixed
Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study June 2, 2021 Journal of Medical Virology 164 Mixed
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial July 1, 2021 The Lancet 45 Mixed
Ivermectin compared with placebo in the clinical evolution of Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial May 23, 2022 Preprint 66 Mixed
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial Aug. 26, 2022 Trials 72 Mixed
Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial Feb. 23, 2021 Infectious Disease Reports 106 Not Supportive
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 March 4, 2021 Journal of American Medical Association 476 Not Supportive
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients May 4, 2021 BMC Infectious Diseases 66 Not Supportive
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial July 2, 2021 BMC Infectious Diseases 501 Not Supportive
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities Feb. 18, 2022 Journal of American Medical Association 490 Not Supportive
Effect of combined use of ivermectin and colchicine in COVID-19 patients June 22, 2022 Egyptian Journal of Anesthesia 135 Not Supportive
Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19 July 19, 2022 Preprint 96 Not Supportive
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 Aug. 18, 2022 New England Journal of Medicine 1323 Not Supportive
Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial Oct 20, 2022 Expert Review of Anti-infective Therapy unclear Not Supportive
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 Oct. 25, 2022 Journal of American Medical Association 1591 Not Supportive
Note: Only studies from the database linked to by the FDA that have been completed and have had results released are included



To read the entire article click here.